Chromatics Color Sciences International. Inc; CCSI Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI

CCSI 24.53

-1.8%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mama Bear who wrote (3416)	6/23/1998 8:50:00 PM
From: CatLady	Read Replies (2) of 5736

Did this part of Asensio's report get posted today? I found it very interesting. "Chromatics has admitted that it "never considered" instrument sales to have "major income potential" in the bilirubin market. It claims that a majority of its revenues will come from sales of a disposable calibration and contamination guard that will be required for each test performed using its instrument. This means that the Chromatics device needs to be recalibrated, or at least verified, after each use and that it requires contact with the patient's skin. These characteristics are crude and totally unnecessary. Simple inexpensive color measurement devices are readily available that can perform the required operation precisely without physical contact or the need for recalibration after each use." asensio.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next